Latest New Zealand News

NRW Holdings reported robust FY25 results with $3.3 billion revenue and $207.9 million underlying EBITA, boosted by strategic acquisitions including Fredon Industries. The company raised its FY26 guidance, projecting revenue near $4.1 billion and EBITA between $260 million and $265 million, underpinned by a $20.9 billion project pipeline.

PeopleIN Limited is set to divest its majority stake in Techforce Personnel, securing over a 100% return and strengthening its balance sheet to fuel future acquisitions.

Algorae Pharmaceuticals has secured a key distribution agreement with global giant Dr. Reddy’s Laboratories to supply the chemotherapy drug Capecitabine in Australia, marking a significant step in its oncology commercialisation strategy.

Reece Limited has announced a new on-market share buyback of up to $35 million, following its recent $365 million off-market buyback, signaling continued confidence in its capital management strategy.

New Zealand King Salmon reported an FY25 net loss driven by a shortened reporting period and biological challenges, while advancing its Blue Endeavour pilot project despite delays. The company projects a cautious recovery in FY26 with EBITDA guidance between NZD 9 million and 15 million.

New Zealand King Salmon Investments Limited has revealed a significant 44% decline in revenue alongside a net loss of NZD 6.3 million for the eight months ending September 2025, signaling challenges ahead for the seafood producer.

New Zealand King Salmon reports a $6.3 million net loss for an eight-month FY25 period, reflecting operational challenges and a shortened reporting cycle, while outlining cautious optimism for FY26 with targeted growth investments.

Ryman Healthcare reported a 13% revenue increase to NZD 413.8 million for H1 2025, yet swung to a significant net loss of NZD 45.2 million and suspended dividends, raising questions about its financial trajectory.

Ryman Healthcare reports a significant financial turnaround with its first positive free cash flow in over ten years, alongside upgraded sales and cost-saving targets for FY26 and completion of a major NZD 2 billion refinancing.

Ryman Healthcare has reported its first positive free cash flow in over a decade, driven by cost reductions and stronger sales momentum, while upgrading its sales guidance for FY26.

Tower Limited has reported a record underlying profit for FY25, driven by improved claims ratios, customer growth, and strategic initiatives including expanded risk-based pricing. The insurer declared increased dividends and outlined a positive growth outlook for FY26.

National Storage REIT has received a conditional, non-binding proposal from a Brookfield and GIC consortium to acquire all stapled securities at $2.86 each, triggering an exclusivity period for negotiations.